- 5 resultados
menor preço: € 149,99, preço mais alto: € 161,99, preço médio: € 158,62
1
Heart Failure - Gregory R. Bock; Jamie A. Goode
Encomendar
no/na lehmanns.de
€ 161,99
Encomendar
Detalhes e envio
Link patrocinado
Gregory R. Bock; Jamie A. Goode:

Heart Failure - primeira edição

2006, ISBN: 9780470029329

Molecules, Mechanisms and Therapeutic Targets, eBooks, eBook Download (PDF), 1. Auflage, Heart failure is the main cause of death and disability in theindustrialized world. There is a maj… mais…

Custos de envio:Does not ship to your country., mais custos de envio
fechar(X)
2
Heart Failure: Molecules, Mechanisms And Therapeutic Targets - Bock
Encomendar
no/na textbooks.com
$ 170,00
(aproximadamente € 157,13)
Envio: € 0,001
Encomendar
Detalhes fornecedor
Link patrocinado

Bock:

Heart Failure: Molecules, Mechanisms And Therapeutic Targets - livro usado

ISBN: 9780470029329

A digital copy of "Heart Failure: Molecules, Mechanisms And Therapeutic Targets" by Bock. Download is immediately available upon purchase! 9780470029329,0470029323,heart,failure,molecules… mais…

Download INSTANTLY! Format: VitalSource. Type: . Copying: Allowed, .2Â.182 selections may be copied daily for 2Â.1825 days. Printable: Allowed, .10Â.182 prints daily for 10Â.1825 days. Expires: No Expiration. Read Aloud?: Allowed. Sharing: Not Allowed. Software: Online: No additional software required <br> Offline: VitalSource Bookshelf. Shipping to USA only! Textbooks. Custos de envio: EUR 0.00
fechar(X)
3
Heart Failure
Encomendar
no/na Hugendubel.de
€ 161,99
Encomendar
Detalhes e envio
Link patrocinado
Heart Failure - novo libro

ISBN: 9780470029329

*Heart Failure* - Molecules Mechanisms and Therapeutic Targets / pdf eBook für 161.99 € / Aus dem Bereich: eBooks, Fachthemen & Wissenschaft, Wissenschaften, allgemein Medien > Bücher nei… mais…

Custos de envio:Does not ship to your country., mais custos de envio
fechar(X)
4
Heart Failure - Gregory R. Bock; Jamie A. Goode
Encomendar
no/na lehmanns.de
€ 161,99
Envio: € 29,951
Encomendar
Detalhes fornecedor
Link patrocinado
Gregory R. Bock; Jamie A. Goode:
Heart Failure - primeira edição

2006, ISBN: 9780470029329

Molecules, Mechanisms and Therapeutic Targets, eBooks, eBook Download (PDF), 1. Auflage, [PU: John Wiley & Sons], John Wiley & Sons, 2006

Custos de envio:Download sofort lieferbar. (EUR 29.95)
fechar(X)
5
Heart Failure - Gregory R. Bock; Jamie A. Goode
Encomendar
no/na lehmanns.de
€ 149,99
Envio: € 0,001
Encomendar
Detalhes fornecedor
Link patrocinado
Gregory R. Bock; Jamie A. Goode:
Heart Failure - primeira edição

2006, ISBN: 9780470029329

eBooks, eBook Download (PDF), 1. Auflage, [PU: Wiley], Wiley, 2006

Custos de envio:Download sofort lieferbar. (EUR 0.00)
fechar(X)
1Como algumas plataformas não transmitem condições de envio e estas podem depender do país de entrega, do preço de compra, do peso e tamanho do artigo, de uma possível adesão à plataforma, de uma entrega directa pela plataforma ou através de um terceiro fornecedor (Marketplace), etc., é possível que os custos de envio indicados pelo eurolivro não correspondam aos da plataforma ofertante.

Dados bibliográficos do melhor livro correspondente

Pormenores referentes ao livro
Heart Failure
Autor:
Título:
Número ISBN:

9780470029329

Dados detalhados do livro - Heart Failure


EAN (ISBN-13): 9780470029329
ISBN (ISBN-10): 0470029323
Ano de publicação: 2006
Editor/Editora: John Wiley & Sons
302 Páginas
Língua: eng/Englisch

Livro na base de dados desde 2007-05-01T20:56:45+01:00 (Lisbon)
Página de detalhes modificada pela última vez em 2023-10-19T06:41:09+01:00 (Lisbon)
Número ISBN/EAN: 9780470029329

Número ISBN - Ortografia alternativa:
0-470-02932-3, 978-0-470-02932-9
Ortografia alternativa e termos de pesquisa relacionados:
Autor do livro: goode

Dados da editora

Autor: Gregory R. Bock; Jamie A. Goode
Título: Novartis Foundation Symposium; Heart Failure - Molecules, Mechanisms and Therapeutic Targets
Editora: Wiley; John Wiley & Sons
302 Páginas
Ano de publicação: 2006-11-02
Língua: Inglês
152,99 € (DE)
Not available (reason unspecified)

EA; E107; E-Book; Nonbooks, PBS / Biologie/Mikrobiologie; Biologie, Biowissenschaften; Biotechnologie; Biotechnologie i. d. Biowissenschaften; Biotechnology; Biowissenschaften; Cardiovascular Disease; Cell & Molecular Biology; Kardiovaskuläre Erkrankungen; Life Sciences; Medical Science; Medizin; Zell- u. Molekularbiologie; Zell- u. Molekularbiologie; Biotechnologie i. d. Biowissenschaften; Kardiovaskuläre Erkrankungen; BB

Introduction (Eric N. Olson). Control of cardiac hypertrophy and heart failure by histoneacetylation/deacetylation (Eric N. Olson, Johannes Backs andTimothy A. McKinsey) . Discussion. A novel mechanism of mechanical stress-induced hypertrophy(Hiroshi Akazawa, Yunzeng Zou and Issei Komuro) . Discussion. Controlling cardiomyocyte survival (N. de Jonge, M. J.Goumans, Daan Lips, Rutger Hassink, Eva J. Vlug, Roy van der Meel,Christopher Donald Emmerson, Joppe Nijman, Leon de Windt and PieterA. Doevendans) . Discussion. Mechanisms of angiotensin II-dependent progression to heartfailure (Mona Nemer, Nassim Dali-Youcef, Hao Wang, Anne Ariesand Pierre Paradis) . Discussion. Alterations in myocardial gene expression as a basis forcardiomyopathies and heart failure (Matthew R. Taylor andMichael R. Bristow) . Discussion. Role of the insulin-like growth factor 1(IGF1)/phosphoinositide-3-kinase (PI3K) pathway mediatingphysiological cardiac hypertrophy (Julie R. McMullen and SeigoIzumo). Discussion. Role of Akt in cardiac growth and metabolism(Anthony J.Muslin and Brian DeBosch). Discussion. Novel therapy for heart failure and exercise-induced ventriculartachycardia based on 'fixing' the leak in ryanodinereceptors (Andrew R. Marks). Discussion. General discussion I. Phospholamban as a therapeutic modality in heart failure(Guoxiang Chu and Evangelia G. Kranias). Discussion. Sarcomere protein gene mutations and inherited heart disease: ab-cardiac myosin heavy chain mutation causing endocardialfibroelastosis and heart failure (Mitsuhiro Kamisago, Joachim P.Schmitt, Dennis McNamara, Christine Seidman and Jonathan G.Seidman). Discussion. The cardiomyocyte cell cycle (Pascal J. E. Lafontant andLoren J. Field). Discussion. Restoration of cardiac function with progenitor cells (CarmenUrbich, Lothar Rössig and Stefanie Dimmeler). Discussion. Signalling pathways in cardiac regeneration (Maria PaolaSantini, Nadine Winn and Nadia Rosenthal). Discussion. Beyond small molecule drugs for heart failure: prospects forgene therapy (Kenneth R. Chien). Discussion. Dual roles of telomerase in cardiac protection and repair(Michael D. Schneider). Discussion. Final general discussion. Closing remarks: historical perspective (Arnold M.Katz). Index of contributors. Subject index.
< Para arquivar...